With our analysis, based on IDO-1 expression, we strongly encourage to consider a possible IDO-1 inhibition therapy IDO-1 expression-driven and this could be the way to overcome the resistance observed in melanoma patients treated with IDO-1 inhibitors. The gene discussed is IDO1; the disease is melanoma.